Regulation of Plasmodium-specific CD4+ T Cells

疟原虫特异性 CD4 T 细胞的调节

• 批准号: 9214981
• 负责人: Noah Sullivan Butler
• 金额: $ 11.13万
• 依托单位: UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-26 至 2017-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9214981
• 关键词: Address; Adoptive Transfer; Affect; Agonist; Antibodies; Antibody Response; Antigen-Presenting Cells; Antigens; B-Lymphocytes; Bacterial Infections; Blood; Bone Marrow; CD4 Positive T Lymphocytes; Cell Communication; Cell physiology; Cell surface; Cells; Cellular Immunity; Cellular biology; Characteristics; Child; Chronic; Communicable Diseases; Communication; Comparative Study; Contracts; Cytokine Signaling; Data; Disease; Dissection; Emergency Situation; Employee Strikes; Environment; Exhibits; Experimental Models; Generations; Genetic; Goals; Helper-Inducer T-Lymphocyte; Host resistance; Human; Humoral Immunities; Immune; Immune response; Immunity; Immunology; Immunotherapy; Infection; Inflammation; Inflammatory; Intervention; Link; Malaria; Malignant Neoplasms; Mediating; Modeling; Mus; Parasite Control; Parasites; Pathway interactions; Physiological; Plasmodium; Plasmodium falciparum; Proteins; Publishing; Reagent; Regulation; Reporting; Research; Resistance; Risk; Role; Severities; Staging; Stimulus; Structure of germinal center of lymph node; System; T-Lymphocyte; Testing; Virulence; Virus Diseases; Work; base; burden of illness; functional restoration; global health; hemozoin; immunoregulation; improved; improved functioning; insight; killings; member; microbial; pathogen; receptor; receptor expression; research study; therapeutic target; tumor necrosis factor ligand superfamily member 4; tumor necrosis factor receptor superfamily member 4

PROJECT SUMMARY Plasmodium infections and the disease malaria remain global health emergencies. Malaria affected more than 200 million people last year, killing nearly 600,000. Antibody responses that target the parasite are essential for controlling parasite replication and limiting the severity of malaria. Potent antibody responses and optimally stimulated B cells require `help' from CD4+ T cells. Our published work has shown that CD4+ T cell function is markedly impaired following Plasmodium infection. We linked the reduced function of CD4+ T cells to the induction of co-inhibitory receptor expression, a class of T cell surface expressed proteins that directly limit the ability of CD4+ T cells to orchestrate protective immune responses against microbial pathogens. We further showed that blocking the activity of co-inhibitory receptors during malaria restored CD4+ T cell function, promoted strong antibody responses and accelerated parasite control and clearance from the infected host. Recently, we identified that we can also restore the function of Plasmodium-specific CD4+ T cells by activating OX40, a member of a class of T cell stimulating receptors. Our new data show that therapeutically stimulating the OX40 receptor during the second week of experimental Plasmodium infection overcomes co- inhibitory networks, markedly improves CD4+ T cell activity and secreted antibody responses, and limits malaria parasite replication. Importantly, we also identified parallels in children infected with P. falciparum, establishing the relevance and significance of our discoveries and strengthening the scientific premise of the current proposal. In this project we apply new cellular, genetic and parasitological reagents to study how the OX40 receptor regulates communication between parasite specific CD4+ T cells and B cells and the generation of antibody responses. Our scientific questions and experimental approaches facilitate our long- term goal to identify new immune-based approaches to therapeutically stimulate host resistance against malaria. Our goal is addressed by three specific aims that will determine: 1) the distinct characteristics of Plasmodium infection that uniquely regulate the functional expression of OX40 receptors on CD4+ T cells; 2) whether the OX40 receptor is required for effective communication between CD4+ T cells and B cells to generate potent antibody responses; and 3) whether B cell expression of the OX40 ligand is regulated by parasite byproducts and necessary for generating potent secreted antibody responses. Our proposed studies and new reagents provide tractable systems and a detailed framework for sustainable extensions of this project that will establish additional new paradigms for enhancing CD4+ T cell-mediated immunity against Plasmodium. Insight gained during the course of our studies will help us identify and develop new immune- based strategies to limit Plasmodium disease burden.

项目摘要 疟原虫感染和疟疾仍然是全球卫生紧急情况。疟疾的影响超过 去年有2亿人死亡，近60万人死亡。针对寄生虫的抗体反应是必不可少的， 控制寄生虫复制和限制疟疾的严重程度。有效的抗体反应和最佳 受刺激的B细胞需要CD 4 + T细胞的“帮助”。我们发表的工作表明，CD 4 + T细胞功能是 在疟原虫感染后明显受损。我们将CD 4 + T细胞功能的降低与 共抑制受体表达的诱导，这是一类T细胞表面表达的蛋白质，其直接限制T细胞的增殖。 CD 4 + T细胞协调针对微生物病原体的保护性免疫应答的能力。我们进一步 显示阻断疟疾期间共抑制受体的活性恢复了CD 4 + T细胞功能， 促进了强烈的抗体反应，加速了寄生虫的控制和从受感染宿主中的清除。 最近，我们发现，我们也可以恢复疟原虫特异性CD 4 + T细胞的功能， 激活OX 40，一种T细胞刺激受体。我们的新数据显示， 在实验性疟原虫感染的第二周期间刺激OX 40受体克服了共- 抑制网络，显着提高CD 4 + T细胞活性和分泌的抗体反应，并限制 疟原虫复制重要的是，我们还发现了感染恶性疟原虫的儿童， 确立我们发现的相关性和重要性，并加强科学前提 目前的提案。在这个项目中，我们应用新的细胞，遗传和寄生虫学试剂来研究如何 OX 40受体调节寄生虫特异性CD 4 + T细胞和B细胞之间的通讯， 产生抗体反应。我们的科学问题和实验方法促进了我们长期的- 长期目标是确定新的基于免疫的方法，以治疗刺激宿主对 疟疾我们的目标是通过三个具体目标来实现的，这三个目标将决定：1） 疟原虫感染，其独特地调节CD 4 + T细胞上OX 40受体的功能性表达; 2） OX 40受体是否是CD 4 + T细胞和B细胞之间有效通讯所必需的， 产生有效的抗体应答;和3）OX 40配体的B细胞表达是否受 寄生虫的副产物和产生有效的分泌抗体反应所必需的。我们建议的研究 新试剂提供了易于处理的系统和可持续扩展的详细框架， 该项目将建立额外的新范例，用于增强CD 4 + T细胞介导的免疫力， 疟原虫在我们的研究过程中获得的洞察力将帮助我们识别和开发新的免疫- 限制疟原虫疾病负担的战略。